Australia Biologics Festival 2024

20th -

21th

February 2024 |

Crown Promenade, Melbourne

Advancing Biologics R&D, Manufacturing, Technology & Innovation in Australia

20th -

21th

February 2024 |

Crown Promenade, Melbourne

📅 Add to Google Calendar

0 +

Attendees

0 +

Companies

0 +

Speakers

0 +

In-Person Networking Hours

0 +

Case Studies

Concept

Excellence in Clinical Trials, Biologics Innovation and Expanded Manufacturing for Australia’s Future Biologics Industry.

With a biotechnology sector benchmarked for global excellence due to world-class facilities, researchers and regulation, Australia has a promising future for biologics innovation and manufacturing. The path ahead will require a focus on further commercial translation of research, and as such partnerships and collaborations will be critical. Expanding sovereign manufacturing in Australia will also play a massive role in uplifting the sector in the country.

The Australia Biologics Festival 2024 is Australia's premier conference that aims to gather the innovators, pioneers ,leaders in the Biologics fraternity including Biologics,Biosimilars, Vaccines, CGT and evolving therapeutics to showcase the latest from ideation to commercialisation phase and beyond. The themes of Investment in Australia and Promoting Clinical Trials in Australia in featured tracks. It brings the right environment to meet the entire biopharma fraternity under one roof.

Join us to bring investment to Australia’s bio sector and explore a wealth of opportunities in world-class clinical trials and biologics innovation as well as expanding the country’s manufacturing footprint.

Australia Biologics Festival 2024

To stay informed about event updates, including date, venue, and agenda, please subscribe to our newsletter on our event website. You can also follow our official social media channels for real-time updates and announcements.

Our event is designed to cater to a wide range of professionals within the biopharmaceutical industry, including researchers, scientists, executives, regulatory experts, and professionals involved in drug development and manufacturing.

The conference will provide a comprehensive learning experience covering various aspects of the dynamic biopharmaceutical industry, ensuring attendees gain valuable insights and knowledge.

Participants can expect to gain insights from industry experts, network with peers, and stay up-to-date with the latest trends and innovations in biopharmaceuticals.

To register for the event, please visit our registration page on our website. You’ll find detailed instructions and options for registration, including pricing and deadlines.

We welcome presentation submissions. If you’re interested in speaking at the event, please visit our “Call for Speakers” page on our website for submission guidelines and deadlines.

Yes, we offer sponsorship and exhibition opportunities for businesses and organizations. Please visit our “Sponsorship Opportunities” page on our website for more information.

We are committed to ensuring the safety and well-being of all attendees. We will implement rigorous safety measures in line with local health guidelines and regulations. Specific safety measures will be communicated closer to the event date to ensure they align with the most up-to-date health recommendations. Rest assured, your safety is our priority.

Yes, we have networking sessions, workshops, and social events scheduled throughout the event to facilitate connections and collaborations among attendees.

Yes, we have a cancellation and refund policy in place. Please refer to our “Cancellation Policy” on our website for details on how to request a refund if you are unable to attend.

THANK YOU TO OUR SPONSORS

SPEAKERS

Featuring esteemed voices from the biopharmaceutical sector. Our selected experts will share insights on the latest trends, challenges, and developments in this dynamic field. Engage in unique discussions, learn about cutting-edge scientific discoveries, and explore the future of biopharmaceuticals with these influential thought leaders. Don't miss this chance to broaden your understanding of this ever-evolving industry.

Alyce Maksoud

Senior GMP Inspector |Team Leader Inspections Section- Manufacturing Quality Branch| Medical Devices and Product Quality-Health Products Regulation Group

Australian Government Department of Health

Australia

Anne Collins

Chief Executive Officer

Sementis ,

Australia

Balaji Somasundaram

Senior CMC Project Manager

Denteric

Australia

Craig Newton

Director

VivaZome Therapeutics

Australia

Gavin Painter

Professor

Victoria University of Wellington-Ferrier Research Institute

Wellington, New Zealand

Harsha Gupta

Senior Manager, Manufacturing and Process Development

Cynata Therapeutics Limited

Ian Nisbet

Chief Operating Officer

Cartherics

Australia

Jerry Kanellos

Chief Operating Officer

Immuron

Australia

Jim Vadolas

Research Group Head- Immuno-haematology

Hudson Institute of Medical Research

Australia

John Power

Group Leader- Regulated Biomanufacturing,

CSIRO

Australia

Larisa Chisholm

Chief Operating Officer

Denteric,

Australia

Mike Gerometta

Head of Process Development, Analytical & Formulation Science

Opthea

Australia

Nicole Van Der Weerden

Chief Operating Officer

Arovella therapeutics

Australia

Pall Thordarson

Professor & Director- RNA Institute,

UNSW

Australia

Pat Thomas

Senior Manager- Supply Chain

Amgen

Australia

Paul McDonald

Chief Executive Officer

IDT

Australia

Penelope Lane

Chief Executive Officer,

Esfam Biotech

Australia

Rasa Ruseckaite

Deputy Head, Clinical Outcomes Data Reporting And Research Program (CORRP), Qualitative Research

Monash University

Australia

Susie Nilsson

Research Director Biomedical Manufacturing

CSIRO

Australia

Tam Nguyen

Deputy Director of Research

St. Vincent’s Hospital

Australia

Tertia Dex

Chief Manufacturing & Development Officer

HaemaLogiX

Australia

Tim Oldham

CEO and Managing Director

Adalta

Australia

Xenia Sango

CEO and Managing Director

Vivazome Therapeutics

Australia

DELEGATE REGISTRATION

Catch the limited super access in time to save BIG!

BIOPHARMA/BIG PHARMA/ACADEMIC

Limited Super (18th August 2023)
SGD 1,880

Limited Special (20th October 2023)
SGD 2,150 

Early Bird (22nd December 2023)
SGD 2,420

Standard Price
SGD 2,690

Limited Group Packages

BUY2,GET3
BUY3,GET5


Poster Presentation:
SGD 400 
Site Tour:
SGD 400

SOLUTION PROVIDER

Limited Super (18th August 2023)
SGD 3,710

Limited Special (20th October 2023)
SGD 4,040

Early Bird (22nd December 2023)
SGD 4,250

Standard Price
SGD 4,590
Group Discount for Solution Providers & General Public:
Buy 3 and get 10% off, Buy 5 get 20% off, Buy 6 and above, get 25% off

Site Tour:
SGD 400

FEATURED CONTENT

Investing in New Zealand Biopharma

Biologics Manufacturing Landscape in Australia

Cell & Gene Therapy in Australia and New Zealand

Key Trends in the ANZ Biopharma Industry

Australia Biologics Industry Overview

Infographic: Australia & NZ Biopharma Market

ABF23_Ebook-cover-1500-x-1500-1-1024x1024

Part 2: Key Future Trends & Innovations in the Australian Biopharma Industry 2023

Key Future Trends & Innovations in the Australian Biopharma Industry 2023

Concept

THANK YOU TO OUR SPONSORS

SPEAKERS

Alyce Maksoud

Senior GMP Inspector |Team Leader Inspections Section- Manufacturing Quality Branch| Medical Devices and Product Quality-Health Products Regulation Group

Anne Collins

Chief Executive Officer

Balaji Somasundaram

Senior CMC Project Manager

Craig Newton

Director

Gavin Painter

Professor

Harsha Gupta

Senior Manager, Manufacturing and Process Development

Ian Nisbet

Chief Operating Officer

Jerry Kanellos

Chief Operating Officer

Jim Vadolas

Research Group Head- Immuno-haematology

John Power

Group Leader- Regulated Biomanufacturing,

Larisa Chisholm

Chief Operating Officer

Mike Gerometta

Head of Process Development, Analytical & Formulation Science

Nicole Van Der Weerden

Chief Operating Officer

Pall Thordarson

Professor & Director- RNA Institute,

Pat Thomas

Senior Manager- Supply Chain

Paul McDonald

Chief Executive Officer

Penelope Lane

Chief Executive Officer,

Rasa Ruseckaite

Deputy Head, Clinical Outcomes Data Reporting And Research Program (CORRP), Qualitative Research

Susie Nilsson

Research Director Biomedical Manufacturing

Tam Nguyen

Deputy Director of Research

Tertia Dex

Chief Manufacturing & Development Officer

Tim Oldham

CEO and Managing Director

Xenia Sango

CEO and Managing Director

DELEGATE REGISTRATION

Catch the limited super access in time to save BIG!

FEATURED CONTENT

#BUZZ ABOUT THE EVENT

SIMILAR EVENTS

ABOUT IMAPAC

OUR SERVICES

GET IN TOUCH

FOLLOW US ON

Download Post Event Report Form

Download Attendee List

Download Prospectus Document Form

Download Brochure Document Form

Sponsorship Form

Download Agenda Form

Download Featured Content Form

Customised Webinar/Webcast

Download Customised Events Brochure

Contact us for Third Party Email Services

Download Newsletter Press Kit

Download Network Meetings Prospectus

Download Media Kit Brochure

Download Form